Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11269939rdf:typepubmed:Citationlld:pubmed
pubmed-article:11269939lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C0025234lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C0178587lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C1706211lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C0007961lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C1546426lld:lifeskim
pubmed-article:11269939lifeskim:mentionsumls-concept:C1548280lld:lifeskim
pubmed-article:11269939pubmed:issue2lld:pubmed
pubmed-article:11269939pubmed:dateCreated2001-3-28lld:pubmed
pubmed-article:11269939pubmed:abstractTextThe influence of melittin on two DMPA membrane systems at pH 4.2 and 8.2 has been investigated by solid-state 31P and 2H NMR, as a function of temperature and peptide concentration. Melittin promotes greater morphological changes for both systems in the fluid phase, the effect being larger at pH 4.2. Close inspection of fatty acyl chain dynamics suggests that some parallels can be drawn between the DMPA/melittin at pH 8.2 and PC/melittin systems. In addition, at pH 8.2 a direct neutralization at the interface of one of the lipid negative charges by a positive charge of the peptide occurs, as can be monitored by 31P NMR at the molecular level. For the system at pH 4.2 and at high temperature, a lipid-to-peptide molar ratio of 30 is sufficient to transform the whole system into an isotropic phase, proposed to be inverted micelles. When the system is cooled down towards the gel phase one observes an intermediate hexagonal phase in a narrow range of temperature.lld:pubmed
pubmed-article:11269939pubmed:languageenglld:pubmed
pubmed-article:11269939pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269939pubmed:citationSubsetIMlld:pubmed
pubmed-article:11269939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269939pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269939pubmed:statusMEDLINElld:pubmed
pubmed-article:11269939pubmed:monthFeblld:pubmed
pubmed-article:11269939pubmed:issn0009-3084lld:pubmed
pubmed-article:11269939pubmed:authorpubmed-author:DufourcqJJlld:pubmed
pubmed-article:11269939pubmed:authorpubmed-author:CamposAAlld:pubmed
pubmed-article:11269939pubmed:authorpubmed-author:PostKKlld:pubmed
pubmed-article:11269939pubmed:authorpubmed-author:AbadCClld:pubmed
pubmed-article:11269939pubmed:authorpubmed-author:DufourcE JEJlld:pubmed
pubmed-article:11269939pubmed:authorpubmed-author:MailletJ CJClld:pubmed
pubmed-article:11269939pubmed:issnTypePrintlld:pubmed
pubmed-article:11269939pubmed:volume109lld:pubmed
pubmed-article:11269939pubmed:ownerNLMlld:pubmed
pubmed-article:11269939pubmed:authorsCompleteYlld:pubmed
pubmed-article:11269939pubmed:pagination209-23lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:meshHeadingpubmed-meshheading:11269939...lld:pubmed
pubmed-article:11269939pubmed:year2001lld:pubmed
pubmed-article:11269939pubmed:articleTitleThe lipid charge density at the bilayer surface modulates the effects of melittin on membranes.lld:pubmed
pubmed-article:11269939pubmed:affiliationCentre de Recherche Paul Pascal, CNRS, Pessac, France.lld:pubmed
pubmed-article:11269939pubmed:publicationTypeJournal Articlelld:pubmed